ABBV vs ZBH
By Alex · Tickerpine
AbbVie Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ZBH |
|---|---|---|
| Price | $265.79 | $100.24 |
| Market cap | $469.68B | $19.12B |
| P/E ratio | 74.7 | 24.5 |
| ROE | — | 6.41% |
| Profit margin | 9.80% | 9.48% |
| Revenue growth | 10.20% | 4.80% |
| Dividend yield | 2.62% | 0.95% |
| Beta | 0.28 | 0.46 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ZBH in plain English
- ABBV is the bigger company — about 24.6× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 24.5 vs 74.7).
- ABBV is growing revenue faster (10% vs 5%).
- ABBV has the higher dividend yield (2.62% vs 0.95%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.